Hs crp
Hs-CRP is a lab equipment product that measures the concentration of C-reactive protein (CRP) in a blood sample. CRP is a biomarker that indicates the presence of inflammation in the body. The Hs-CRP device provides a quantitative measurement of CRP levels, which can be used by healthcare professionals to assess and monitor various medical conditions.
Lab products found in correlation
12 protocols using hs crp
Fasting Lipid and Inflammation Biomarkers
Comprehensive Cardiovascular Risk Assessment
The LDL peak buoyancy and cholesterol distribution across the lipoprotein classes were assessed by density gradient ultracentrifugation (DGUC) for apo B containing lipoproteins, optimized for LDL particles. Thirty-seven 0.45 ml fractions were then collected from the bottom of the centrifuge tube. Cholesterol was measured in each fraction. The relative flotation rate (Rf), which characterizes LDL peak buoyancy, was obtained by dividing the fraction number containing the LDL-cholesterol peak by the total number of fractions collected. Each lipoprotein subclass elution range was defined as previously published [18 (link)]. Circulating levels of osteoprotegerin (OPG) were assessed by using dedicated ELISA kits (R&D System), whereas serum levels of high-sensitivity CRP (hs-CRP) have been measured through a sensitive immunonephelometric method (Dade Behring).
Biomarkers of HIV Progression
Biomarker Measurement in Fasting Samples
Metabolic Measurements in Sleep Disorders
Measuring Inflammatory and Adipokine Markers
Comprehensive Biomarker Profiling in Diabetes
Biomarker Evaluation in HFpEF Subtypes
In addition to determining whether there are differences in pro‐inflammatory biomarkers in AD‐HFpEF versus S‐HFpEF, we also tested whether biomarker levels are associated with echocardiographic‐Doppler abnormalities of left ventricular diastolic function in all comers and are predictive of clinical outcomes in AD‐HFpEF. In the DOSE and ROSE trials short‐term clinical outcomes included urine volume, change in cystatin‐C, change in creatinine, change in NT‐proBNP, and change in weight over the 72 hours after randomization. In addition, post‐discharge clinical status with respect to survival and re‐hospitalizations was determined by telephone call 60 days after randomization for each trial.
Assessment of Serum Pentraxin-3 and hs-CRP Levels
Quantification of Inflammatory Markers
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!